Markets:

Overview

News

Currencies

International

Treasuries

Cigna Corp (NY:CI)

267.40 -7.86 (-2.86%)

Streaming Delayed Price Updated: 10:25 AM EDT, Sep 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

42 43 Next >

Price Over Earnings Overview: Cigna ↗

November 04, 2024

Via Benzinga

MarketBeat Week in Review – 10/28 - 11/1

November 02, 2024

Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentiment

Via MarketBeat

Topics Artificial Intelligence Economy

Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday? ↗

October 31, 2024

Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech earnings triggered the steepest drop in major U.S. indices in nearly two months.

Via Benzinga

NYSE:CI is an undervalued gem with solid fundamentals. ↗

October 28, 2024

THE CIGNA GROUP (NYSE:CI): good value for what you're paying.

Via Chartmill

Investors seeking growth at a reasonable cost should explore NYSE:CI. ↗

October 28, 2024

THE CIGNA GROUP (NYSE:CI) is showing good growth, while it is not too expensive.

Via Chartmill

11 Analysts Assess Cigna: What You Need To Know ↗

October 23, 2024

Via Benzinga

Cigna Group (CI) Q3 2024 Earnings Call Transcript ↗

October 31, 2024

CI earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients ↗

October 31, 2024

Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed.

Via Benzinga

The Cigna Group Reports $63.7 Billion In Q3 Total Revenues, Better Than Expected ↗

October 31, 2024

The Cigna Group has reported impressive financial results for the third quarter of 2024.

Via Talk Markets

Cigna Considers Humana Acquisition – What It Means for the Stocks

October 29, 2024

Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky.

Via MarketBeat

Jim Cramer: Buy Broadcom, But Stay Away From These Stocks ↗

October 25, 2024

The "Mad Money" host recommends buying Broadcom, but staying away from this bus manufacturer. "I just don't see the growth."

Via Benzinga

Here's How Much You Would Have Made Owning Cigna Stock In The Last 15 Years ↗

October 23, 2024

Via Benzinga

$100 Invested In This Stock 15 Years Ago Would Be Worth $1,200 Today ↗

October 08, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Cigna Through 11 Analysts ↗

October 01, 2024

Via Benzinga

Why Cigna Group Stock Got Mashed on Monday ↗

October 21, 2024

A media report stated that the company is determined to grow with a major merger deal.

Via The Motley Fool

Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday? ↗

October 21, 2024

U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the...

Via Benzinga

Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms ↗

October 21, 2024

Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue.

Via Benzinga

Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key ↗

October 21, 2024

Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.

Via Investor's Business Daily

NYSE:CI: good value for what you're paying. ↗

September 30, 2024

THE CIGNA GROUP (NYSE:CI) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

NYSE:CI is showing good growth, while it is not too expensive. ↗

September 30, 2024

For those who appreciate growth without the sticker shock, THE CIGNA GROUP (NYSE:CI) is worth considering.

Via Chartmill

Market Briefing For Monday, Oct 21 ↗

October 21, 2024

Investors need to recognize that this time of year not only are more 'shakeouts' than we've seen likely; but tax-selling and shuffling (rearranging the Titanic deckchairs to some degree) is to be...

Via Talk Markets

SAP, Nucor And 3 Stocks To Watch Heading Into Monday ↗

October 21, 2024

Via Benzinga

Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO ↗

October 18, 2024

CVS Health replaces CEO Karen Lynch with David Joyner as the company struggles with lower earnings projections and rising medical costs. Q3 2024 results, including a $1.1 billion charge, are expected...

Via Benzinga

CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit ↗

October 09, 2024

The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises...

Via Benzinga

3 Dividend Growth Stocks Set to Supercharge Your Portfolio

October 06, 2024

Cigna Group, CDW, and Coterra Energy are three stocks that offer a strong history of dividend payouts and the potential for continued dividend growth.

Via MarketBeat

Topics ETFs

Shamus McGuire Champions Advanced Technology Integration in New Jersey’s Healthcare Sector

October 04, 2024

Via Get News

Topics Artificial Intelligence

Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000% ↗

October 03, 2024

Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes...

Via Benzinga

Topics Lawsuit

Healthcare Executive Shamus McGuire Highlights Work-Life Balance in New Jersey

October 02, 2024

New Jersey, US, 2nd October 2024, ZEX PR WIRE, Shamus McGuire, […]

Via Zexprwire

CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report ↗

October 01, 2024

CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017.

Via Benzinga

CVS Health in Focus as Activist Investor Prepares for High-Level Talks ↗

September 30, 2024

CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit.

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.